Working with Community Advisory Boards for COVID-19 related clinical studies
23 April 2020
| COVID-19: Risk communication and community engagement
Overview
In this document, the WHO Good Participatory Practice (GPP) Technical Working Group shares information on establishing and working with different types of advisory groups in the context of COVID-19 clinical studies.
Community engagement is widely promoted in health research to:
- strengthen the protection of, respect for, and empowerment of, participant communities
- improve the relevance and quality of research
WHO Team
R&D Blue Print (RDB),
WHO Headquarters (HQ)